Ron Zwanziger
Chief Executive Officer presso LUMIRADX LIMITED
Patrimonio netto: 5 M $ in data 31/12/2023
Profilo
Ronald Zwanziger is the founder of MediSense, Inc. (founded in 1981), Alere, Inc. (founded in 2001), LumiraDx Ltd.
(Cayman Islands) (founded in 2014), LumiraDx UK Ltd.
(founded in 2014), and LumiraDX Ltd.
(founded in 2014).
He held the titles of Chairman & Chief Executive Officer at MediSense, Inc. and President, Chief Executive Officer & Director at Alere, Inc. Currently, Mr. Zwanziger holds positions as a Director at Persivia, Inc., Persivia Holdings, Inc., LumiraDx Group Ltd., LumiraDx International Ltd., and Treisar Investments Ltd.
In the past, he served as Chairman, President & Chief Executive Officer at Inverness Medical Technology, Inc. from 1992 to 2001, Non-Executive Chairman at EKF Diagnostics Holdings Plc from 2015 to 2016, and Independent Director at AMAG Pharmaceuticals, Inc. from 2006 to 2011.
Mr. Zwanziger obtained an undergraduate degree from Imperial College London in 1975 and an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
LUMIRADX LIMITED
27.35% | 01/11/2023 | 42 180 049 ( 27.35% ) | 3 M $ | 31/12/2023 |
LUMIRADX LIMITED
17.92% | 31/12/2022 | 37 184 803 ( 17.92% ) | 2 M $ | 31/12/2023 |
Posizioni attive di Ron Zwanziger
Società | Posizione | Inizio |
---|---|---|
LUMIRADX LIMITED | Chief Executive Officer | 01/11/2014 |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Chief Executive Officer | 01/11/2014 |
LumiraDx Group Ltd.
LumiraDx Group Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Group Ltd. is a next generation point of care diagnostic platform that was founded in 2014. The private company is based in London, UK and is transforming community-based healthcare with lab comparable results in minutes. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing by utilizing its innovative qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. | Director/Board Member | 01/09/2014 |
LumiraDx International Ltd.
LumiraDx International Ltd. Medical DistributorsDistribution Services Part of LumiraDx Ltd. (Cayman Islands), LumiraDx International Ltd. is a wholesaler of pharmaceutical goods. The private company is based in London, UK. LumiraDx International was founded in 2014. | Director/Board Member | 10/07/2014 |
Persivia Holdings, Inc.
Persivia Holdings, Inc. Financial ConglomeratesFinance Persivia Holdings, Inc. engages in the provision of holdings services. The company was founded in 2015 and is headquartered in Lowell, MA. | Director/Board Member | - |
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | Chief Executive Officer | 01/01/2014 |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | Director/Board Member | 23/12/2015 |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | Director/Board Member | - |
Precedenti posizioni note di Ron Zwanziger
Società | Posizione | Fine |
---|---|---|
EKF DIAGNOSTICS HOLDINGS PLC | Chairman | 08/04/2016 |
░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Ron Zwanziger
Imperial College London | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EKF DIAGNOSTICS HOLDINGS PLC | Health Technology |
LUMIRADX LIMITED | Health Technology |
Aziende private | 11 |
---|---|
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Health Technology |
Alere, Inc.
Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Inverness Medical Technology, Inc.
Inverness Medical Technology, Inc. Pharmaceuticals: OtherHealth Technology Inverness Medical Technology, Inc. develops, manufactures and markets healthcare products for diabetes and for women through its retail distribution networks. The company was incorporated in September 9, 1992 and is headquartered in Waltham, Massachusetts. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Persivia, Inc.
Persivia, Inc. Packaged SoftwareTechnology Services Persivia, Inc. provides a clinical decision support and reporting analytics platform. It aggregates, analyzes and reports clinical data sets in the healthcare industry. The firm offers patient-centric clinical decision support, population health management, intelligent order sets, disease surveillance and regulatory reporting services. The company was founded by Mansoor Khan and is headquartered in Lowell, MA. | Technology Services |
Persivia Holdings, Inc.
Persivia Holdings, Inc. Financial ConglomeratesFinance Persivia Holdings, Inc. engages in the provision of holdings services. The company was founded in 2015 and is headquartered in Lowell, MA. | Finance |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Health Technology |
LumiraDx Group Ltd.
LumiraDx Group Ltd. Medical SpecialtiesHealth Technology Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Group Ltd. is a next generation point of care diagnostic platform that was founded in 2014. The private company is based in London, UK and is transforming community-based healthcare with lab comparable results in minutes. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing by utilizing its innovative qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. | Health Technology |
LumiraDx International Ltd.
LumiraDx International Ltd. Medical DistributorsDistribution Services Part of LumiraDx Ltd. (Cayman Islands), LumiraDx International Ltd. is a wholesaler of pharmaceutical goods. The private company is based in London, UK. LumiraDx International was founded in 2014. | Distribution Services |
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | Health Technology |
Treisar Investments Ltd.
Treisar Investments Ltd. Financial ConglomeratesFinance Treisar Investments Ltd. provides investment services. The private company is based in London, UK and was founded in 2015. | Finance |
- Borsa valori
- Insiders
- Ron Zwanziger